Affimed NV - AFMD Company Short-Term Debt

Graphic logo of Affimed (AFMD)

This daily price chart for Affimed (AFMD) on the GURU.Markets platform reflects the 0.00 metric. The business is critically dependent on success in lymphoma treatment, while liquidity remains sufficient. The development of immune regulators relies on streamlined supply chains, which reduces costs. Particular attention is paid to the transportation of biologics, where strict adherence to shipping conditions guarantees therapeutic efficacy.

AFMD (affimed.com) Company Short-Term Debts history from 07/04/2022 to 05/31/2025

Affimed NV - analytical breakdowns and key metrics (AFMD)

- price and consensus price forecast:
Price Chart Affimed Therapeutics|AFMD - Fair Value Consensus
- market capitalization data:
Market Value Affimed N.V.|AFMD - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Affimed|AFMD - Book Capitalization|Market Cap to Net Assets Ratio affimed.com|AFMD - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Affimed|AFMD - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Affimed Therapeutics|AFMD - Company Total Debt|Debt to Book Capitalization Ratio Affimed N.V.|AFMD - Company Long-Term Liabilities|Company Current Liabilities Affimed
Fundamental company valuation:affimed.com - AFMD
Product sample of Affimed Therapeutics

This indicator measures the aggregate of liabilities maturing within twelve months, allowing an investor to filter out market volatility via debt with a maturity of up to one year and assess the issuer's actual solvency. For Affimed (AFMD), this metric is critical, as the outsourcing of late-stage development and production of biologics shifts capital expenditures into the category of short-term operational payments to counterparties.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Upstream Bio Corp - Company Short-Term Debts|ZBIO - Company Short-Term Debts|Company Short-Term Debts Immunome, Inc. (IMNM)|gossamerbio.com (GOSS) - Current Liabilities|Company Short-Term Debts KalVista Pharmaceuticals, Inc. KALV|Current Liabilities Septerna, Inc.|PVLA (Pieris Pharmaceuticals Inc) - Company Short-Term Debts|Short-Term Debt Volume SVRA (Savara Pharma)|Rigel Pharmaceuticals - Company Short-Term Debt|Company Current Liabilities anaptysbio.com ANAB|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debts|ENGN - Short-Term Debt|Company Short-Term Debts RAPT Therapeutics|Aerovate Therapeutics (JBIO) - Company Short-Term Indebtedness|ACRS (Aclaris Therapeutics) - Company Short-Term Debts|Company Short-Term Debts kyvernatx.com|TLSA - Company Short-Term Debts|Current Liabilities CABA (Cabaletta Bio Inc.)|Ventyx Bio - Company Short-Term Debt|Company Current Liabilities Theratechnologies, Inc THTX|Avalo Therapeutics, Inc (AVTX) - Company Short-Term Debts|ELDN: Company Short-Term Indebtedness|Company Short-Term Debt Agenus Inc. (AGEN)|Climb Bio Inc. (CLYM) - Current Liabilities|ZURA - Company Short-Term Debts|Company Short-Term Loans and Borrowings aTyr Pharmaceuticals|Company Short-Term Debts ADAG|Company Short-Term Debts IMA (ikenaoncology.com)|Company Short-Term Debt Shattuck Labs|Equillium Inc - Company Short-Term Loans and Borrowings|CNTB: Company Short-Term Debt|IMUX - Company Current Liabilities|ATRA: Company Short-Term Debts|Company Short-Term Debts InflaRx|XFOR - Company Current Liabilities|Company Short-Term Loans and Borrowings Adicet|CELU (Celularity Inc.) - Company Short-Term Debts|Short-Term Debt Volume INMB (INmune Bio Corporation)|Barinthus Biotherapeutics - Company Short-Term Debt|kezarlifesciences.com - Company Current Liabilities|SABS: Company Short-Term Debt|Akari Therapeutics PLC (AKTX) - Company Current Liabilities|ENLV: Company Current Liabilities|QTTB (Q32 Bio) - Company Short-Term Debts|Company Short-Term Debt GeoVax Labs, Inc. (GOVX)|Company Short-Term Indebtedness edesabiotech.com|iBio - Company Short-Term Debts|Short-Term Debt carismatx.com (CARM)|Company Short-Term Debts XTLB (XTL Biopharmaceuticals, Ltd.)|Company Short-Term Debts Bolt Biotherapeutics Inc. BOLT|Company Short-Term Debts HCW Biologics Inc|APVO - Current Liabilities|Company Short-Term Debts AIM ImmunoTech Inc. (AIM)|Aditxt, Inc. (ADTX) - Current Liabilities|GRI: Company Short-Term Debts|Short-Term Debt Volume XRTX|Company Short-Term Debt HIND (Vyome Holdings Inc)|Company Current Liabilities revbiosciences.com (REVB)|INDP: Company Short-Term Debts|Short-Term Debt Scinai Immunotherapeutics Ltd SCNI|CalciMedica Corp (CALI) - Company Short-Term Debts|ALLK - Company Short-Term Indebtedness|HOOK: Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debts|Company Short-Term Debts iTeos Therapeutics, Inc. ITOS|Current Liabilities OCEA|Company Short-Term Debt TCBP (TC BioPharm (Holdings) PLC)|Company Current Liabilities Third Harmonic Bio Inc (THRD)